New Jersey Patent of the Month – April 2023
Abon Pharmaceuticals LLC has developed a long-acting injectable formulation of lurasidone that promises to revolutionize the treatment of schizophrenia and bipolar depression.
Schizophrenia and bipolar depression are chronic conditions that require consistent treatment. However, non-adherence to medication regimens is common, leading to poor prognosis and a host of other issues. The non-aqueous long-acting injectable formulation developed by Abon Pharmaceuticals addresses this issue by providing a predictable drug-release profile over a defined period of time following each injection.
Lurasidone is a highly effective atypical antipsychotic drug with low metabolic effects, unlike other atypical antipsychotics like clozapine, olanzapine, and quetiapine. However, its oral bioavailability is low, which limits its efficacy. Abon’s long-acting injectable formulation increases the bioavailability of lurasidone, which allows for lower dosing frequencies, improved efficacy, and reduced side effects. Additionally, the injection provides very high assurance of patient compliance and decreased incidence of side effects.
Abon’s team of scientists and chemists utilize advanced techniques and modern equipment to identify and characterize physicochemical properties essential to formulate and process complex dosage forms. Their long-acting injectable formulation of lurasidone offers an innovative solution to the challenge of non-adherence to medication regimens. By providing a predictable drug-release profile, increased bioavailability, lower dosing frequencies, and reduced side effects, it has the potential to improve the lives of millions of people suffering from schizophrenia and bipolar depression.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
